全文获取类型
收费全文 | 15269篇 |
免费 | 1306篇 |
国内免费 | 1205篇 |
专业分类
耳鼻咽喉 | 106篇 |
儿科学 | 142篇 |
妇产科学 | 226篇 |
基础医学 | 1852篇 |
口腔科学 | 326篇 |
临床医学 | 2175篇 |
内科学 | 2469篇 |
皮肤病学 | 117篇 |
神经病学 | 845篇 |
特种医学 | 617篇 |
外国民族医学 | 11篇 |
外科学 | 1664篇 |
综合类 | 2368篇 |
现状与发展 | 3篇 |
一般理论 | 3篇 |
预防医学 | 865篇 |
眼科学 | 362篇 |
药学 | 1521篇 |
12篇 | |
中国医学 | 806篇 |
肿瘤学 | 1290篇 |
出版年
2024年 | 50篇 |
2023年 | 259篇 |
2022年 | 657篇 |
2021年 | 866篇 |
2020年 | 575篇 |
2019年 | 520篇 |
2018年 | 559篇 |
2017年 | 441篇 |
2016年 | 450篇 |
2015年 | 675篇 |
2014年 | 849篇 |
2013年 | 703篇 |
2012年 | 1090篇 |
2011年 | 1208篇 |
2010年 | 699篇 |
2009年 | 642篇 |
2008年 | 793篇 |
2007年 | 767篇 |
2006年 | 740篇 |
2005年 | 764篇 |
2004年 | 489篇 |
2003年 | 492篇 |
2002年 | 439篇 |
2001年 | 338篇 |
2000年 | 389篇 |
1999年 | 433篇 |
1998年 | 266篇 |
1997年 | 242篇 |
1996年 | 204篇 |
1995年 | 203篇 |
1994年 | 144篇 |
1993年 | 103篇 |
1992年 | 129篇 |
1991年 | 84篇 |
1990年 | 81篇 |
1989年 | 76篇 |
1988年 | 61篇 |
1987年 | 73篇 |
1986年 | 51篇 |
1985年 | 52篇 |
1984年 | 26篇 |
1983年 | 17篇 |
1982年 | 5篇 |
1981年 | 10篇 |
1980年 | 6篇 |
1979年 | 9篇 |
1968年 | 4篇 |
1964年 | 4篇 |
1954年 | 3篇 |
1931年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Background:The findings on the effectiveness of platelet-rich plasma, ozone, and hyaluronic acid in the treatment of osteoarthritis of the knee are controversial, and the existing original studies and meta-analyses are mostly comparisons of a single joint cavity injection method, lacking direct and indirect comparisons of different drugs in the joint cavity. The lack of direct and indirect comparisons of different drugs in the joint cavity makes it difficult to have a clearer and more comprehensive understanding of joint cavity injection methods. In this study, the efficacy of platelet-rich, ozone, sodium hyaluronate, and combined knee cavity injections were compared directly or indirectly using a reticulated meta-analysis in this field, and the efficacy of treatment measures was ranked to provide more comprehensive and reliable evidence-based clinical evidence for the selection of knee cavity injections in osteoarthritis of the knee.Objective:To compare the effects of platelet-rich plasma, ozone, and sodium glassate injection interventions on the efficacy of osteoarthritis of the knee through reticulated Meta-analysis, and to comprehensively compare the clinical effectiveness of platelet-rich plasma, ozone, and sodium glassate injection joint cavity injection for the treatment of osteoarthritis of the knee.Methods:The PubMed, CBM, CNKI, VIP, and Wan-Fang databases were searched for information on the effectiveness of platelet-rich plasma, ozone, and sodium vitrate injection for the comparative treatment of osteoarthritis of the knee, with a search time frame of each database from the date of creation to July 20, 2021. Two investigators independently screened the literature, extracted data according to inclusion and exclusion criteria, and evaluated the quality of the literature in parallel. Statistical analysis was performed using Stata 16.0 software to compare the differences in the efficacy of each treatment measure using the ratio and 95% confidence interval as effect indicators and to rank the efficacy.Results:Thirty-three RCTs with 7003 patients with osteoarthritis of the knee were included, involving 5 therapeutic measures. Meta-analysis showed that the efficacy of platelet-rich plasma injection was superior to both ozone and hyaluronic acid therapies. Hyaluronic acid+ozone and platelet-rich plasma+hyaluronic acid were both superior to ozone and hyaluronic acid monotherapy. The differences in efficacy between hyaluronic acid and ozone compared with platelet-rich plasma were statistically significant, and the differences in efficacy between the 2 combination therapies (platelet-rich plasma+hyaluronic acid, hyaluronic acid+ozone) and the 3 monotherapies (platelet-rich plasma, ozone, hyaluronic acid) were statistically significant. Platelet-rich plasma+hyaluronic acid, hyaluronic acid+ozone compared with 3 monotherapies (platelet-rich plasma, ozone, hyaluronic acid) were statistically significant, except for the difference in efficacy with platelet-rich plasma, which was not statistically significant, indicating that this platelet-rich plasma+hyaluronic acid and Hyaluronic acid+ozone combination therapy was superior to monotherapy. Also, the efficacy of platelet-rich plasma was better than hyaluronic acid and ozone and the difference was statistically significant, indicating that platelet-rich plasma was more effective than ozone and sodium glass in the treatment of osteoarthritis of the knee in monotherapy.Conclusion:It is believed that in the course of clinical practice, hyaluronic acid+ozone or platelet-rich plasma+hyaluronic acid combination therapy or platelet-rich plasma therapy can be preferred for patients with osteoarthritis of the knee. 相似文献
52.
目的 分别评价ZTA(ZrO2增韧Al2O3)和Al2O3陶瓷的性能,探索一种适合制备正畸托槽的陶瓷材料.方法 选用ZrO2(3mol%Y2O3)和α-Al2O3粉体作为原料,利用热压铸成型工艺制备陶瓷托槽,在1600 ℃下烧结.将制得样品进行各方面的性能测试.结果 采用纯Al2O3制备的托槽抗弯强度远远低于ZTA复合陶瓷.结论 牙科正畸托槽可以选用具有较高抗弯强度的ZTA复合陶瓷作为原料. 相似文献
53.
Electrochemical Corrosion Behaviour of X70 Steel under the Action of Capillary Water in Saline Soils
In this paper, the electrochemical corrosion behavior of X70 steel in saline soil under capillary water was simulated by a Geo-experts one-dimensional soil column instrument. A volumetric water content sensor and conductivity test were used to study the migration mechanism of water and salt (sodium chloride) under the capillary water. The electrochemical corrosion behavior of the X70 steel in the corrosion system was analyzed by electrochemical testing as well as the macroscopic and microscopic corrosion morphology of the steel. The test results showed that the corrosion behavior of X70 steel was significantly influenced by the rise of capillary water. In particular, the wetting front during the capillary water rise meant that the X70 steel was located at the three-phase solid/liquid/gas interface at a certain location, which worsened its corrosion behavior. In addition, after the capillary water was stabilized, the salts were transported with the capillary water to the top of the soil column. This resulted in the highest salt content in the soil environment and the most severe corrosion of the X70 steel at this location. 相似文献
54.
Jing Zhao Kaixin Ding Manting Hou Yuanhua Li Xiaorong Hou Wenzhang Dai Zhiyong Li Jun Zhao Wenlong Liu Zhaofang Bai 《Pharmaceutical biology》2022,60(1):958
ContextSchisandra chinensis (Turcz.) Baill. (Magnoliaceae) essential oil (SCEO) composition is rich in lignans that are believed to perform protective effects in the liver.ObjectiveThis study investigates the effects of SCEO in the treatment of acetaminophen (APAP)-induced liver injury in mice.Materials and methodsC57BL/6 mice (n = 56) were randomly divided into seven groups: normal; APAP (300 mg/kg); APAP plus bicyclol (200 mg/kg); APAP plus SCEO (0.25, 0.5, 1, 2 g/kg). Serum biochemical parameters for liver function, inflammatory factors, and antioxidant activities were determined. The protein expression levels of Nrf2, GCLC, GCLM, HO-1, p62, and LC3 were assessed by western blotting. Nrf2, GCLC, HO-1, p62, and LC3 mRNA were detected by real-time PCR.ResultsCompared to APAP overdose, SCEO (2 g/kg) pre-treatment reduced the serum levels of AST (79.4%), ALT (84.6%), TNF-α (57.3%), and IL-6 (53.0%). In addition, SCEO (2 g/kg) markedly suppressed cytochrome P450 2E1 (CYP2E1) (15.4%) and attenuated the exhaustion of GSH (43.6%) and SOD (16.8%), and the accumulation of MDA (22.6%) in the liver, to inhibit the occurrence of oxidative stress. Moreover, hepatic tissues from our experiment revealed that SCEO pre-treatment mitigated liver injury caused by oxidative stress by increasing Nrf2, HO-1, and GCL. Additionally, SCEO activated autophagy, which upregulated hepatic LC3-II and decreased p62 in APAP overdose mice (p < 0.05).Discussion and conclusionsOur evidence demonstrated that SCEO protects hepatocytes from APAP-induced liver injury in vivo and the findings will provide a reliable theoretical basis for developing novel therapeutics. 相似文献
55.
Zhiguo Ma Yue Li Zhensheng Cao Shaoqiang Zhang Shengjun Hou Jilin Liu Xin Ruan 《Materials》2022,15(10)
For the Honghe Bridge project located in Yunnan Province, Southwest China, a steel/ultrahigh-performance concrete (UHPC) composite deck is used in the suspension bridge with a 700 m main span, and the steel stud connectors are used in the 50 mm–thick UHPC layer. To investigate the shrinkage behavior of UHPC and the relevant influence, the in situ time-dependent strain is measured continuously, and within the 20-day curing time, the material behavior is summarized based on test results. This paper proposes a prediction model for UHPC shrinkage which is refined from the widely used B3 model for normal concrete material, and the parameter values are modified and optimized by experimental comparison. Combining the numerical model and the finite element analysis model of the composite deck, the detailed mechanical state in structural parts is studied. For the practical construction, the simulation results indicate that the small thickness of UHPC above the stud and weak bond strength can influence the eventual structural performance greatly. In the discussion of stress distribution at different locations of the deck, the potential crack on the edge and the corner of the UHPC–steel interface and the mechanical damage on the stud connector around are also indicated. 相似文献
56.
Ye Y Cheng X Luo HB Liu L Li YB Hou YP 《Journal of assisted reproduction and genetics》2008,25(8):389-394
Purpose The aim of the study was to evaluate the association of CYP1A1 and CYP1B1 polymorphisms with uterine leiomyoma in Chinese
women.
Methods We investigated 100 women with clinically diagnosed uterine leiomyoma and 110 healthy normal subjects from Chinese women.
The genetic distribution of two CYP1A1 polymorphisms at MspI, Ile462Val and four CYP1B1 polymorphisms at Arg48Gly, Ala119Ser,
Leu432Val, Asp449Asp were analyzed by polymerase chain reaction–restriction fragment length polymorphism and DNA sequencing
method.
Results All the SNPs showed polymorphisms in Chinese women. The genotype A/G and the allele G on Ile462Val was significantly different
between uterine leiomyoma patients and controls (P < 0.05).
Conclusion These results suggest that the genotype of CYP1A1 Ile462Val was associated with the increased risk of uterine leiomyomas in
Chinese women.
Capsule This is the first report that demonstrates the polymorphism at Ile462Val of CYP1A1 to be associated with uterine leiomyoma
in Chinese women. 相似文献
57.
目的 评估临床采用氟尿嘧啶类药物联合奥沙利铂治疗晚期转移性小肠癌的临床效果及安全性.方法 回顾性分析近6年来于本院接受化学治疗的89例晚期小肠癌患者的一般资料,按照治疗方法的不同进行等均分组,其中45例患者采取FOLFOX(奥沙利铂、亚叶酸钙、氟尿嘧啶)治疗方案,纳入对照组,另外44名患者采取XELOX(奥沙利铂联合卡培他滨)方案,作为观察组.观察两组临床效果以及用药不良反应,并在随访过程中观察两组中位疾病进展时间.结果 观察组总有效率优于对照组(61.36%比55.55%),但组间差异无统计学意义(P>0.05);观察组毒副反应发生率高于对照组(36.3%比31.1%),但差异无统计学意义(P>0.05).结论 采用氟尿嘧啶类药物联合奥沙利铂治疗晚期转移性小肠癌安全有效,毒副反应可耐受,可作为不可手术切除或转移性小肠癌的一线化疗选择,但仍需要大量数据样本做进一步研究证实. 相似文献
58.
59.
Chunrui Bo Tianqi Wang Chengbei Hou Jinming Han Lixia Chen Huixue Zhang Lihua Wang Hongyan Li 《CNS Neuroscience & Therapeutics》2022,28(8):1229
BackgroundTo assess the temporal changes in the characteristics of ischemic stroke drug clinical trials conducted in mainland China in 2005–2021.MethodsA statistical analysis of registered clinical trials on ischemic stroke was performed using the platform of the Center for Drug Evaluation of China National Medical Products Administration, the Chinese Clinical Trial Registry, and ClinicalTrials.gov websites.ResultsFrom January 1, 2005 to August 1, 2021, a total of 384 registered drug clinical trials on ischemic stroke were identified in mainland China. Over time, the number of trials gradually increased each year, with a significant growth in 2014, from 16 in 2013 to 42 in 2014. Phase IV trials (31.8%) accounted for the majority, followed by phase II (16.4%), phase I (10.9%), and phase III (8.6%). In terms of sponsorship, the proportion of investigator‐initiated trials (IITs) (60.7%) was higher than industry‐sponsored trials (ISTs) (39.3%). Additionally, trials involving traditional Chinese medicines (TCMs) (36.2%) accounted for the largest proportion, followed by trials involving antithrombotic therapy (19.5%) and cerebral protection agents (16.7%). Furthermore, over the past 17 years, the number of leading drug clinical trial units for ischemic stroke in mainland China has continuously increased. The leading principal units from Beijing, Shanghai, Guangdong, Jiangsu, and Liaoning accounted for the majority of the trials (67.4%).ConclusionIn the past 17 years, great progress has been made in the research and development (R&D) of drugs and clinical trials for ischemic stroke in mainland China. The most extensive progress was observed in TCMs, antithrombotic therapy, and cerebral protection agents. More clinical trials are needed to confirm whether the newly developed drugs can improve the clinical efficacy of ischemic stroke. Simultaneously, more pharmaceutical R&D efforts of innovative drugs are warranted. 相似文献
60.